Before validating these constructs in rat primary neurons, we further validated rat-specific sgRNAs in C6 cells (a dividing rat glioma cell line) using nucleofection of dCas9-VPR and sgRNA plasmids targeting either LacZ or the rat Fos gene (Fig. 1C). The gene discussed is FOS; the disease is central nervous system cancer.